131 related articles for article (PubMed ID: 29029424)
1. microRNA-22 can regulate expression of the long non-coding RNA MEG3 in acute myeloid leukemia.
Yao H; Sun P; Duan M; Lin L; Pan Y; Wu C; Fu X; Wang H; Guo L; Jin T; Ding Y
Oncotarget; 2017 Sep; 8(39):65211-65217. PubMed ID: 29029424
[TBL] [Abstract][Full Text] [Related]
2. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis.
Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C
J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.
Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L
Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.
Li JQ; Hu SY; Wang ZY; Lin J; Jian S; Dong YC; Wu XF; Dai-Lan ; Cao LJ
Biomed Pharmacother; 2016 Oct; 83():905-911. PubMed ID: 27522004
[TBL] [Abstract][Full Text] [Related]
6. [MiR-199a-5p Affects Sensitivity of Acute Myeloid Leukemia to Adriamycin by Targeting DRAM1].
Li Y; Sun Y; Miao M; Shi X; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1096-1104. PubMed ID: 32798383
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone up-regulates long non-coding RNA MEG3 to protect endothelial progenitor cells via increasing HDAC7 expression in metabolic syndrome.
Liu HZ; Wang QY; Zhang Y; Qi DT; Li MW; Guo WQ; Ma YH; Wang LY; Chen Y; Gao CY
Biomed Pharmacother; 2016 Mar; 78():101-109. PubMed ID: 26898430
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
Shibayama Y; Kondo T; Ohya H; Fujisawa S; Teshima T; Iseki K
Oncol Rep; 2015 May; 33(5):2176-82. PubMed ID: 25759982
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y; Lou J; Yang Y; Feng J; Hao Y; Huang S; Yin L; Xu J; Huang D; Ma B; Zou D; Wang Y; Zhang Y; Zhang B; Chen P; Yu K; Lam EW; Wang X; Liu Q; Yan J; Jin B
Leukemia; 2017 Dec; 31(12):2543-2551. PubMed ID: 28400619
[TBL] [Abstract][Full Text] [Related]
10. Decrease of lncRNA MEG3 in Acute Myeloid Leukemia Affected the Expression of p53 and MDM2.
Jia Y; He E; Peng J; Zhao M
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702691
[TBL] [Abstract][Full Text] [Related]
11. The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5.
Wang Q; Li M; Shen Z; Bu F; Yu H; Pan X; Yang Y; Meng X; Huang C; Li J
Front Pharmacol; 2018; 9():302. PubMed ID: 29692724
[TBL] [Abstract][Full Text] [Related]
12. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression.
Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R
J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106
[TBL] [Abstract][Full Text] [Related]
14. miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM.
Liu X; Liao W; Peng H; Luo X; Luo Z; Jiang H; Xu L
J Cancer Res Clin Oncol; 2016 Jan; 142(1):77-87. PubMed ID: 26113450
[TBL] [Abstract][Full Text] [Related]
15. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21.
Zhou X; Yuan P; Liu Q; Liu Z
Biomol Ther (Seoul); 2017 Sep; 25(5):490-496. PubMed ID: 28190319
[TBL] [Abstract][Full Text] [Related]
17. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of BAX, MEG3, and miR-214-3P genes in recurrent pregnancy loss.
Al-Rubaye S; Ghaderian SMH; Salehpour S; Salmani T; Vojdani S; Yaseen R; Akbarzadeh R
Gynecol Endocrinol; 2021 Jul; 37(7):660-664. PubMed ID: 33719810
[TBL] [Abstract][Full Text] [Related]
19. AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B.
Zhang J; Zheng Y; Liu H; Liu B
Blood Lymphat Cancer; 2024; 14():17-30. PubMed ID: 38550556
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
Tang LJ; Sun GK; Zhang TJ; Wu DH; Zhou JD; Ma BB; Xu ZJ; Wen XM; Chen Q; Yao DM; Qian J; Ma JC; Lin J
Cancer Cell Int; 2019; 19():177. PubMed ID: 31333331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
